Where it comes from
- Made in
- Many cell types
- Sent out by
- Not secreted
- Acts on
- P-bodies, the granules where messenger RNA is stored and destroyed
What it does
- The number of P-bodies in a cell runs opposite to how much NoBody it holds: raise the peptide and the granules disperse, lower it and more of them form 1
- Joins the machinery that removes the cap from messenger RNA before decay, and changes how much of a decay-targeted transcript survives 1
- Found in 2017 among hundreds of unannotated peptides turned up by proteomic surveys of human cells 2
In medicine
- None. NoBody acts inside the cell on messenger RNA, so it is neither a blood test nor something that could be given
- No human disease has been tied to NBDY, which is unsurprising: the gene was catalogued for years as a long non-coding RNA, so nobody looked for a protein in it 2
Beyond the body’s own use
- Nothing is in trials. The interest is what NoBody says about annotation: a sequence filed as non-coding encodes a peptide with a job, found only because surveys began hunting for products of short open reading frames 2
- The open question is whether P-body numbers can be set on purpose, and what that does to the lifetime of particular messenger RNAs; the work is still in cell lines 1
Sources
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.